231 related articles for article (PubMed ID: 2340524)
1. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
Brothman AR; Peehl DM; Patel AM; McNeal JE
Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic studies of prostatic cancer.
Lundgren R
Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
[TBL] [Abstract][Full Text] [Related]
3. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
5. [Cytogenetic investigations in primary prostate carcinomas].
Szücs S; Zitzelsberger H; Roter M; Bauchinger M; Höfler H
Verh Dtsch Ges Pathol; 1993; 77():138-41. PubMed ID: 7511272
[TBL] [Abstract][Full Text] [Related]
6. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
[TBL] [Abstract][Full Text] [Related]
7. A molecular cytogenetic analysis of 7q31 in prostate cancer.
Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
[TBL] [Abstract][Full Text] [Related]
8. [Significance of numerical chromosome aberrations in prostate cancer].
Henke RP; Krüger E; Ayhan N; Hübner D; Hammerer P
Verh Dtsch Ges Pathol; 1993; 77():133-7. PubMed ID: 7511271
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
[TBL] [Abstract][Full Text] [Related]
10. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia.
Ueshima Y; Fukuhara S; Nagai K; Takatsuki K; Uchino H
Cancer Res; 1983 Feb; 43(2):905-12. PubMed ID: 6401225
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
15. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
[TBL] [Abstract][Full Text] [Related]
18. [Abnormalities of chromosome involving 1q in uterine endometrial carcinomas].
Fujita H; Wake N; Sakai K; Hashimoto M; Okuyama K; Kutsuzawa T; Ichinoe K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):236-42. PubMed ID: 3457090
[TBL] [Abstract][Full Text] [Related]
19. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
Kondo K; Chilcote RR; Maurer HS; Rowley JD
Cancer Res; 1984 Nov; 44(11):5376-81. PubMed ID: 6091875
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetic study of endometrial carcinoma].
Fujita H
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):546-55. PubMed ID: 3019854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
